Plain-English translation of NCT05959434 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combined therapy approach that brings together two well-established talk therapy methods: Cognitive Processing Therapy (for PTSD) and Relapse Prevention (for alcohol use disorder). The study aims to see whether combining these two approaches in a single, coordinated program helps people recover better when they're dealing with both trauma and alcohol use problems.
Many people struggle with both PTSD and alcohol use disorder at the same time, and when these conditions occur together, they tend to be more severe and harder to treat. Most mental health providers currently try to mix these treatments on their own, which can lead to inconsistent care. This trial was created to develop and test a standardized, proven combination therapy so that people can receive consistent, high-quality treatment.
You likely qualify if…
You likely don't qualify if…
You would attend 12 individual therapy sessions, each lasting 90 minutes, delivered twice per week over about 6 weeks (with flexibility to extend to 9 weeks if needed). During these sessions, you'll learn skills to identify and manage triggers for drinking, cope with cravings, address unhelpful thoughts about alcohol and your trauma, and work through trauma-related beliefs with your therapist. The entire program combines both the alcohol recovery and trauma recovery elements in each session.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States